Recent Developments in Oncology Immunotherapy, Adverse Effects Part 2
Recent Developments in Oncology Immunotherapy, Adverse Effects Part 2
About this item
Full title
Author / Creator
Publisher
Philadelphia: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
Philadelphia: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Immunotherapy has emerged as a promising treatment for cancer survivors in the past few years. This new treatment is associated with unique immune-related toxicities that can range from mild to life-threatening. Early recognition, referral, and monitoring by primary care nurse practitioners may improve the quality of life and survival of cancer sur...
Alternative Titles
Full title
Recent Developments in Oncology Immunotherapy, Adverse Effects Part 2
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2023365659
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2023365659
Other Identifiers
ISSN
1555-4155
E-ISSN
1878-058X
DOI
10.1016/j.nurpra.2017.11.012
